Related Experiment Video
Updated: Feb 25, 2026
13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10.8K
Adjuvant formulations for virus-like particle (VLP) based vaccines
Velasco Cimica1, Jose M Galarza1
1TechnoVax, Inc., 765 Old Saw Mill River Road, Tarrytown, NY 10591, United States.
Clinical Immunology (Orlando, Fla.)
|August 7, 2017
Summary
Virus-like particle (VLP) vaccines are enhanced with adjuvants to improve efficacy. Novel adjuvants offer advanced strategies for optimizing immune responses against challenging viral diseases.
Area of Science:
- Vaccinology
- Immunology
- Biotechnology
Background:
- Virus-like particle (VLP) technology significantly impacts modern vaccinology.
- Adjuvants are crucial for optimizing VLP-based vaccine efficacy and safety.
- Current licensed VLP vaccines primarily use aluminum-based adjuvants.
Purpose of the Study:
- To review advancements in adjuvant technology for VLP-based vaccines against viral diseases.
- To discuss principles for designing adjuvant formulations to enhance vaccine immunogenicity.
Main Methods:
- Literature review of current adjuvant technologies.
- Analysis of adjuvant principles for VLP vaccine design.
Main Results:
- Novel adjuvant classes (liposomes, PRR agonists, etc.) can improve immunostimulatory activity.
- Optimization is needed for challenging pathogens and weak immune responders.
- Adjuvants enhance the magnitude and duration of protective immunity.
Conclusions:
- Adjuvant selection is critical for maximizing VLP vaccine effectiveness.
- Emerging adjuvant strategies hold promise for overcoming limitations of current vaccines.
- Further research into adjuvant design can lead to more potent VLP-based vaccines.
Related Concept Videos
01:29Subviral Agents
653
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
653
01:30Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K